News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
529,622 Results
Type
Article (35448)
Company Profile (162)
Press Release (494003)
Multimedia
Podcasts (80)
Webinars (17)
Section
Business (136210)
Career Advice (1190)
Deals (24889)
Drug Delivery (103)
Drug Development (53058)
Employer Resources (128)
FDA (13468)
Job Trends (11880)
News (234547)
Policy (24955)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2489)
Academic (2)
Accelerated approval (23)
Adcomms (20)
Allergies (119)
Alliances (38446)
ALS (119)
Alzheimer's disease (1331)
Antibody-drug conjugate (ADC) (191)
Approvals (13767)
Artificial intelligence (467)
Autoimmune disease (103)
Automation (33)
Bankruptcy (192)
Best Places to Work (10181)
BIOSECURE Act (11)
Biosimilars (171)
Biotechnology (90)
Bladder cancer (119)
Brain cancer (42)
Breast cancer (439)
Cancer (3245)
Cardiovascular disease (339)
Career advice (1046)
Career pathing (28)
CAR-T (181)
CDC (52)
Celiac Disease (1)
Cell therapy (510)
Cervical cancer (29)
Clinical research (46351)
Collaboration (1379)
Company closure (1)
Compensation (255)
Complete response letters (31)
COVID-19 (2563)
CRISPR (75)
C-suite (627)
Cystic fibrosis (104)
Data (4633)
Decentralized trials (2)
Denatured (32)
Depression (115)
Diabetes (406)
Diagnostics (6234)
Digital health (46)
Diversity (13)
Diversity, equity & inclusion (37)
Drug discovery (189)
Drug pricing (186)
Drug shortages (26)
Duchenne muscular dystrophy (155)
Earnings (49050)
Editorial (47)
Employer branding (11)
Employer resources (118)
Events (90096)
Executive appointments (811)
FDA (16032)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (5)
Frontotemporal dementia (17)
Funding (1241)
Gene editing (140)
Generative AI (41)
Gene therapy (409)
GLP-1 (779)
Government (4688)
Grass and pollen (7)
Guidances (334)
Healthcare (17089)
HIV (55)
Huntington's disease (23)
IgA nephropathy (56)
Immunology and inflammation (157)
Immuno-oncology (41)
Indications (83)
Infectious disease (2826)
Inflammatory bowel disease (148)
Inflation Reduction Act (17)
Influenza (114)
Intellectual property (152)
Interviews (176)
IPO (10807)
IRA (49)
Job creations (2076)
Job search strategy (894)
JPM (64)
Kidney cancer (7)
Labor market (52)
Layoffs (284)
Leadership (28)
Legal (4936)
Liver cancer (68)
Longevity (12)
Lung cancer (399)
Lymphoma (239)
Machine learning (32)
Management (51)
Manufacturing (621)
MASH (135)
Medical device (12378)
Medtech (12430)
Mergers & acquisitions (14954)
Metabolic disorders (1018)
Multiple sclerosis (135)
NASH (17)
Neurodegenerative disease (238)
Neuropsychiatric disorders (69)
Neuroscience (2280)
Neurotech (1)
NextGen: Class of 2026 (5915)
Non-profit (4356)
Now hiring (22)
Obesity (472)
Opinion (207)
Ovarian cancer (105)
Pain (165)
Pancreatic cancer (132)
Parkinson's disease (212)
Partnered (32)
Patents (303)
Patient recruitment (349)
Peanut (45)
People (43576)
Pharmaceutical (37)
Pharmacy benefit managers (29)
Phase 1 (13620)
Phase 2 (19432)
Phase 3 (16470)
Pipeline (4038)
Policy (267)
Postmarket research (1939)
Preclinical (4823)
Press Release (57)
Prostate cancer (174)
Psychedelics (41)
Radiopharmaceuticals (203)
Rare diseases (639)
Real estate (4212)
Recruiting (54)
Regulatory (18915)
Reports (31)
Research institute (2326)
Resumes & cover letters (149)
Rett syndrome (24)
RNA editing (9)
RSV (71)
Schizophrenia (122)
Series A (209)
Series B (162)
Service/supplier (9)
Sickle cell disease (79)
Special edition (12)
Spinal muscular atrophy (116)
Sponsored (41)
Startups (2757)
State (1)
Stomach cancer (8)
Supply chain (89)
Tariffs (56)
The Weekly (47)
Vaccines (938)
Venture capital (73)
Weight loss (300)
Women's health (87)
Worklife (14)
Date
Today (101)
Last 7 days (471)
Last 30 days (1693)
Last 365 days (22944)
2026 (2420)
2025 (23350)
2024 (26903)
2023 (30397)
2022 (40611)
2021 (44822)
2020 (44983)
2019 (40448)
2018 (30344)
2017 (24155)
2016 (24598)
2015 (28690)
2014 (21544)
2013 (17461)
2012 (18590)
2011 (19173)
2010 (16794)
Location
Africa (675)
Alabama (51)
Alaska (7)
Arizona (221)
Arkansas (11)
Asia (30692)
Australia (5229)
California (7914)
Canada (2506)
China (847)
Colorado (373)
Connecticut (383)
Delaware (262)
Europe (72329)
Florida (1227)
Georgia (293)
Hawaii (4)
Idaho (57)
Illinois (712)
India (62)
Indiana (506)
Iowa (15)
Japan (353)
Kansas (105)
Kentucky (32)
Louisiana (26)
Maine (81)
Maryland (1106)
Massachusetts (5609)
Michigan (262)
Minnesota (538)
Mississippi (5)
Missouri (135)
Montana (32)
Nebraska (24)
Nevada (106)
New Hampshire (69)
New Jersey (2489)
New Mexico (25)
New York (2345)
North Carolina (1202)
North Dakota (8)
Northern California (3869)
Ohio (275)
Oklahoma (19)
Oregon (33)
Pennsylvania (1739)
Puerto Rico (14)
Rhode Island (34)
South America (891)
South Carolina (58)
South Dakota (1)
Southern California (3030)
Tennessee (157)
Texas (1196)
United States (30035)
Utah (300)
Vermont (1)
Virginia (181)
Washington D.C. (60)
Washington State (712)
West Virginia (3)
Wisconsin (114)
Wyoming (2)
529,622 Results for "microsoft health solutions group".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bristol Myers Squibb Announces Collaboration with Microsoft to Advance AI-Driven Early Detection of Lung Cancer
January 20, 2026
·
3 min read
Press Releases
NRx Pharmaceuticals (Nasdaq:NRXP) and neurocare Group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depression, PTSD, and other mental health afflictions
January 5, 2026
·
9 min read
Press Releases
Bausch Health’s Aesthetics Business, Solta Medical, Acquires Longtime Distribution Partner, the Shibo Group, to Strengthen Presence in China
December 2, 2025
·
4 min read
Press Releases
Devonian Health Group Reports Financial Results of its First Quarter Ended on October 31, 2025 and Provides Corporate Update
December 15, 2025
·
8 min read
Press Releases
INBRAIN Neuroelectronics Announces Collaboration with Microsoft to Advance Agentic AI for Precision Neurology and Brain-Computer Interface Therapeutics
November 11, 2025
·
3 min read
Press Releases
Devonian Health Group Reports its Fourth Quarter and Annual 2025 Financial Results and Appointment of a New Board Member
November 27, 2025
·
9 min read
Press Releases
Optimi Health to Supply MDMA to MAPS Israel’s Clinical Trial for Trauma-Related PTSD
Approved multicenter study sponsored by Sheba Medical Center to compare group and individual MDMA-assisted therapy for 168 patients experiencing trauma-related PTSD
November 26, 2025
·
6 min read
Press Releases
Optimi Health Completes First 2026 Production of MDMA and Psilocybin Capsules
Australia’s Department of Health has issued import permits for Optimi’s MDMA and psilocybin capsules for use under the Authorised Prescriber Scheme
January 26, 2026
·
1 min read
Press Releases
As mental health patients turn to AI chatbots, how can pharma lead the way?
A new report by Bryter released today reveals where pharma can lead as patients turn to (and question) AI tools for mental health.
February 5, 2026
·
1 min read
Gene therapy
Liver Toxicities Force Pause on Two Dose Groups of UniQure’s Mid-Stage Fabry Study
The gene therapy uses an AAV vector to restore healthy levels of the alpha-galactosidase enzyme, which is rendered dysfunctional in patients with Fabry disease, leading to the toxic build-up of lipids in cells.
February 9, 2026
·
1 min read
·
Tristan Manalac
1 of 52,963
Next
